These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
184 related articles for article (PubMed ID: 34060347)
1. Safety, Tissue Distribution, and Metabolism of LNA-Containing Antisense Oligonucleotides in Rats. Romero-Palomo F; Festag M; Lenz B; Schadt S; Brink A; Kipar A; Steinhuber B; Husser C; Koller E; Sewing S; Tessier Y; Dzygiel P; Fischer G; Winter M; Hetzel U; Mihatsch MJ; Braendli-Baiocco A Toxicol Pathol; 2021 Aug; 49(6):1174-1192. PubMed ID: 34060347 [TBL] [Abstract][Full Text] [Related]
2. In Vivo Metabolite Profiles of an Li XQ; Elebring M; Dahlén A; Weidolf L Drug Metab Dispos; 2023 Oct; 51(10):1350-1361. PubMed ID: 37429729 [TBL] [Abstract][Full Text] [Related]
4. Targeting murine alveolar macrophages by the intratracheal administration of locked nucleic acid containing antisense oligonucleotides. Uemura Y; Kobayashi K Drug Deliv; 2019 Dec; 26(1):803-811. PubMed ID: 31385541 [TBL] [Abstract][Full Text] [Related]
5. The intratracheal administration of locked nucleic acid containing antisense oligonucleotides induced gene silencing and an immune-stimulatory effect in the murine lung. Uemura Y; Hagiwara K; Kobayashi K PLoS One; 2017; 12(11):e0187286. PubMed ID: 29107995 [TBL] [Abstract][Full Text] [Related]
6. Evaluation of bovine milk extracellular vesicles for the delivery of locked nucleic acid antisense oligonucleotides. Grossen P; Portmann M; Koller E; Duschmalé M; Minz T; Sewing S; Pandya NJ; van Geijtenbeek SK; Ducret A; Kusznir EA; Huber S; Berrera M; Lauer ME; Ringler P; Nordbo B; Jensen ML; Sladojevich F; Jagasia R; Alex R; Gamboni R; Keller M Eur J Pharm Biopharm; 2021 Jan; 158():198-210. PubMed ID: 33248268 [TBL] [Abstract][Full Text] [Related]
7. Development of a detection method for antisense oligonucleotides in mouse kidneys by matrix-assisted laser desorption/ionization imaging mass spectrometry. Yokoi H; Kasahara Y; Obika S; Doi T; Kamada H Rapid Commun Mass Spectrom; 2018 Dec; 32(23):1984-1990. PubMed ID: 30152908 [TBL] [Abstract][Full Text] [Related]
8. Evaluation of the effect of 2'-O-methyl, fluoro hexitol, bicyclo and Morpholino nucleic acid modifications on potency of GalNAc conjugated antisense oligonucleotides in mice. Prakash TP; Yu J; Kinberger GA; Low A; Jackson M; Rigo F; Swayze EE; Seth PP Bioorg Med Chem Lett; 2018 Dec; 28(23-24):3774-3779. PubMed ID: 30342955 [TBL] [Abstract][Full Text] [Related]
9. Integrated Assessment of the Clinical Performance of GalNAc Crooke ST; Baker BF; Xia S; Yu RZ; Viney NJ; Wang Y; Tsimikas S; Geary RS Nucleic Acid Ther; 2019 Feb; 29(1):16-32. PubMed ID: 30570431 [TBL] [Abstract][Full Text] [Related]
10. Hepatotoxicity of high affinity gapmer antisense oligonucleotides is mediated by RNase H1 dependent promiscuous reduction of very long pre-mRNA transcripts. Burel SA; Hart CE; Cauntay P; Hsiao J; Machemer T; Katz M; Watt A; Bui HH; Younis H; Sabripour M; Freier SM; Hung G; Dan A; Prakash TP; Seth PP; Swayze EE; Bennett CF; Crooke ST; Henry SP Nucleic Acids Res; 2016 Mar; 44(5):2093-109. PubMed ID: 26553810 [TBL] [Abstract][Full Text] [Related]
11. Hsp90 protein interacts with phosphorothioate oligonucleotides containing hydrophobic 2'-modifications and enhances antisense activity. Liang XH; Shen W; Sun H; Kinberger GA; Prakash TP; Nichols JG; Crooke ST Nucleic Acids Res; 2016 May; 44(8):3892-907. PubMed ID: 26945041 [TBL] [Abstract][Full Text] [Related]
12. Effect of modular conjugation strategy for Yamamoto T; Sawamura M; Terada C; Kashiwada K; Wada F; Yamayoshi A; Obika S; Harada-Shiba M Nucleosides Nucleotides Nucleic Acids; 2020; 39(1-3):109-118. PubMed ID: 31617782 [TBL] [Abstract][Full Text] [Related]